Hong Kong International Biotechnology Park, by the Hong Kong Health Science and Technology Park Limited integration of a number of famous domestic and foreign biotechnology enterprises, the park covers an area of more than 1,000 acres.1, Hong Kong International Biotechnology Park based in Hong Kong, to the world. Science and Technology Park covers an area of 1000 mu, construction area of more than 2 million square meters, incubating 300 biomedical innovation enterprises listed, the total investment of more than 10 billion US dollars.2, Hong Kong International Biotechnology Park construction period of five years, the first phase of the total investment of more than 3 billion US dollars, the second phase of 3.5 billion US dollars, the third phase of 3.5 billion US dollars, the target annual sales revenue of more than 700 billion Hong Kong dollars. 3. The Hong Kong International Biotechnology Park plans to establish a "Hong Kong Biotechnology Industry Guidance Fund" with the Hong Kong SAR Government with a scale of HK $100 billion; Support biotechnology enterprises in the park and introduce 100 strong international biological innovation enterprises from home and abroad. 4. Hong Kong International Biotechnology Park focuses on supporting 30 leading biotechnology enterprises, building no less than 5 large multinational biomedical technology enterprises, and becoming the world famous Hong Kong biotechnology Silicone valley.Wang Yu, the first chairman of Hong Kong Health Science and Technology Park Limited, is former Vice President of Beijing Medical University, former director of Beijing Institute of Hepatology, professor of Tsinghua University, former director of China Center for Disease Control. Core think tank advisory team, A. Former Hong Kong Chief Executive Leung Chun-ying; B. Antony Leung, former Financial Secretary of Hong Kong; C. Zhong Nanshan, Academician of Chinese Academy of Sciences and Chinese Academy of Engineering.

L- Carnitine Material Manufacture